Beta Bionics, Inc. (NASDAQ:BBNX) Insider Purchases $566,950.00 in Stock

Beta Bionics, Inc. (NASDAQ:BBNX) insider Mike Mensinger acquired 33,350 shares of the company’s stock in a transaction on Friday, January 31st. The shares were purchased at an average cost of $17.00 per share, with a total value of $566,950.00. Following the completion of the purchase, the insider now directly owns 59,019 shares of the company’s stock, valued at $1,003,323. This trade represents a 129.92 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Beta Bionics Trading Down 0.7 %

Beta Bionics stock opened at $22.84 on Thursday. Beta Bionics, Inc. has a 12-month low of $21.72 and a 12-month high of $24.50.

Beta Bionics Company Profile

We are a commercial-stage medical device company engaged in the design, development and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease.